Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan.
Pharmacogenomics J
; 21(3): 346-358, 2021 06.
Article
in En
| MEDLINE
| ID: mdl-33649520
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Losartan
/
Hypertension
/
Androstanols
/
Antihypertensive Agents
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
/
Europa
Language:
En
Journal:
Pharmacogenomics J
Journal subject:
BIOLOGIA MOLECULAR
/
FARMACOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: